SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study.
Saved in:
| Title: | SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study. |
|---|---|
| Authors: | Haldar T; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA., Kvale M; Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Douglas MP; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA., Coyote-Maetas W; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.; Quantitative Biosciences Institute, University of California San Francisco, San Francisco, California, USA., Kachuri L; Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA., Witte JS; Department of Epidemiology and Population Health, Stanford University, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.; Department of Biomedical Data Science and Genetics, Stanford University, Stanford, California, USA., Iribarren C; Division of Research, Kaiser Permanente Northern California, Pleasanton, California, USA., Medina MW; Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.; Liver Center, University of California San Francisco, San Francisco, California, USA.; Department of Pediatrics, University of California San Francisco, Oakland, California, USA., Krauss RM; Liver Center, University of California San Francisco, San Francisco, California, USA.; Department of Medicine, University of California San Francisco, Oakland, California, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA., Oni-Orisan A; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.; Institute for Human Genetics, University of California San Francisco, San Francisco, California, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jun; Vol. 117 (6), pp. 1696-1705. Date of Electronic Publication: 2025 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
